Actively Recruiting
Dysautonomia in Children With Type 1 Diabetes
Led by Centre Hospitalier Universitaire de Saint Etienne · Updated on 2026-03-06
100
Participants Needed
1
Research Sites
70 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Some physiological factors, such as physical activity, or pathological factors, such as sepsis or diabetes, are known to modulate the overall autonomic activity and the individual's intrinsic capacity to regulate their sympathetic and parasympathetic balance. These conditions can alter the physiological autonomic balance, sometimes with positive consequences on the FC-breathing control and blood pressure adjustment, depending on the individual's position and the status of blood volume, but sometimes with deleterious effects, such as poor regulation of sinus cardiac activity and respiration rate. Cardiovascular autonomic neuropathy is a major complication of type 1 diabetes. Several studies have described autonomic dysfunction in patients with type 1 diabetes, but these data are derived from cohorts of adults and adolescents or short ECG recordings at rest. Moreover, there are often confounding factors such as sedentary/physical activity, overweight, exposure to post-pubertal hormonal peaks, toxic drugs, or cardiac therapy. These factors don't greatly influence children's autonomic physiological maturation, whereas diabetes can sometimes exist for several years. In this population, the search for cardiac dysautonomia is entirely appropriate.
CONDITIONS
Official Title
Dysautonomia in Children With Type 1 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Parents affiliates or entitled to the French Social Security Fund
- Children under 18 years with type 1 diabetes followed at the University Hospital of Saint-Etienne
- Healthy children under 18 years matched for age (±6 months) and sex, without diabetes or dysautonomia, no anesthesia within 2 months before recording, and not on beta-blocker or antiarrhythmic treatment
You will not qualify if you...
- Children with diabetes diagnosis less than 5 years prior to inclusion
- Children with diseases affecting the central nervous system or brainstem
- Children with serious cardiorespiratory diseases or on cardiac treatment (cardiopathies, rhythmic disorders)
- Children or parents who are foreign or do not speak French
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chu de Saint-Etienne
Saint-Etienne, France, 42055
Actively Recruiting
Research Team
H
Hugues PATURAL, MD PhD
CONTACT
M
Meryem BRITAL, CDP
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here